Merck Sharp & Dohme LLC: Drug Recall
Recall #D-0241-2026 · 12/12/2025
Class II: Risk
Recall Details
- Recall Number
- D-0241-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Merck Sharp & Dohme LLC
- Status
- Ongoing
- Date Initiated
- 12/12/2025
- Location
- Wilson, NC, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3 - single dose kits
Reason for Recall
Presence of particulate matter: potential presence of metal particulates in the product.
Product Description
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Distribution Pattern
Nationwide in the USA
Other Recalls by Merck Sharp & Dohme LLC
- Class II: Risk 12/12/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.